Diffuse cirrhosis-like hepatocellular carcinoma: A clinically and radiographically undetected variant mimicking cirrhosis

American Journal of Surgical Pathology

Volumn 34, Issue 7, 2010, Pages 935-941

  Jakate, Shriram ^a   Yabes, Annoel ^b   Giusto, Deborah ^d   Naini, Bita ^c   Lassman, Charles ^c   Yeh, Matthew M ^e   Ferrell, Linda D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cirrhosis like; diffuse; hepatocellular carcinoma; undetected; variant

Indexed keywords

ALPHA FETOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INCIDENTAL FINDING; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENTAL FINDINGS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 77954216321     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181ddf52f     Document Type: Article

References (23)

1. Bruix J, Sherman M. AASLD practice guideline. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
2. Cabibbo G, Craxi A. Hepatocellular cancer: optimal strategies for screening and surveillance. Dig Dis. 2009;27:142-147.
3. Edmondson HA, Steiner PE. Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462-503.
4. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours, Tumours of the Digestive System. Lyon: IARC Press; 2000.
5. Ishak KG, Goodman ZD, Stocker JT. Hepatocellular carcinoma. In: Rosai J, Sobin L, eds. Tumors of the Liver and Intrahepatic Bile Ducts. Washington DC: Armed Forces Institute of Pathology; 2001: 203-205.
6. Kitao A, Zen Y, Matsui O, et al. Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography\radiologic-pathologic correlation. Radiology. 2009;252:605-614.
7. Lin YW, Lee HS, Chen CH, et al. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q. J Gastroenterol Hepatol. 2005; 20:536-546.
8. Mondada D, Bosman FT, Fontolliet C, et al. Elevated hepatocyte paraffin 1 and neprilysin expression in hepatocellular carcinoma are correlated with longer survival. Virchows Arch. 2006;448:35-45.
9. Morimoto O, Nagano H, Sakon M, et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol. 2003;39:215-221.
10. Ng IO, Na J, Lai EC, et al. Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. Am J Clin Pathol. 1995;104:313-318.
11. Ng IO, Guan X, Poon RT, et al. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol. 2003;199:345-353.
12. Nomoto S, Kinoshita T, Katao K, et al. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer. 2007;97:1260-1265.
13. Nzeako UC, Goodman ZD, Ishak KG. Comparison of tumor pathology the duration of survival of North American patients with hepatocellular carcinoma. Cancer. 1995;76:579-588.
14. Okuda K, Peters RL, Simpson IW. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer. 1984;54:2165-2173.
15. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
16. Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg. 2001;182:177-182.
17. Sotiropoulos GC, Malago M, Molmenti EP, et al. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation. 2006;81:531-535.
18. Strnad P, Zatloukal K, Stumptner C, et al. Mallory-Denk bodies: lessons from keratin-containing hepatic inclusion bodies. Biochim Biophys Acta. 2008;1782:764-774.
19. Urahashi T, Lynch SV, Kim YH, et al. Undetected hepatocellular carcinoma in patients undergoing liver transplantation is associated with favorable outcome. Hepatogastroenterology. 2007;54:1192-1195.
20. Yamamoto T, Kajino K, Kudo M, et al. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology. 1999;29:1446-1452.
21. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: extension of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394-1403.
22. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl. 2002;8:765-774.
23. Zavaglia C, De Carlis L, Alberti AB, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100:2708-2716.